1 Faculdade de Medicina de Botucatu, Unesp, Assis, Brazil;
2 Faculdade de Medicina de Ribeirão Preto, Ribeirao Preto, Brazil;
3 University of State of Bahia, Salvador, Brazil;
4 Universid...
1 Bahia State University UNEB, Salvador, Brazil;
2 Faculdade de Medicina de Botucatu, Botucatu, Brazil;
3 Kaiser Hospital Dia, Department of Coloproctology, São José do Rio Preto, Brazil;...
BACKGROUND:
Inflammatory Bowel Disease (IBD), which can be divided into Crohn’s Disease (CD) and Ulcerative Colitis (UC), is an immune mediated disease featured by gastrointes...
BACKGROUND:
The IBD National Patient Registry is an initiative of the GEDIIB (Brazilian Study Group of Inflammatory Bowel Disease) who aims to survey the epidemiological profi...
1 Faculdade de Medicina de Botucatu, Unesp, Assis, Brazil;
2 Fundação Educacional do Municipio de Assis, Assis, Brazil;
3 Faculdade de Medicina de Botucatu, Botucatu, Brazil.
BACKGROUND: The treatment of ulcerative colitis (UC) remains challenging, with several strategies available. Therapeutic options include aminosalicylates, corticosteroids, immunosuppressa...
BACKGROUND: The main biological agents used to treat Crohn's disease (CD) are anti-TNF agents. Despite its safety profile, the medication is not exempt from side effects such as infe...
BACKGROUND: The main biological agents used to treat Crohn's disease (CD) are anti-TNF agents. Despite its safety profile, the medication is not exempt from side effects such as infection...
BACKGROUND: The Inflammatory Bowel Diseases (IBD), which comprise Crohn’s Disease (CD) and Ulcerative Colitis (UC) are chronic diseases that demand continuous interaction between patients...
CASE: Background: Specialized nursing care makes all the difference in the management of patients with inflammatory bowel disease (IBD). The aim of the study is to report the experie...